Back to Search Start Over

Frequency and characteristics of dysautonomic symptoms in multiple sclerosis: a cross-sectional double-center study with the validated Italian version of the Composite Autonomic Symptom Score-31

Authors :
L. Mancinelli
Matteo Foschi
Alessandra Lugaresi
Beatrice Viti
Giulia Giannini
Pietro Guaraldi
Elena Merli
Corrado Zenesini
Pietro Cortelli
Foschi M.
Giannini G.
Merli E.
Mancinelli L.
Zenesini C.
Viti B.
Guaraldi P.
Cortelli P.
Lugaresi A.
Source :
Neurological Sciences
Publication Year :
2020
Publisher :
Springer Science and Business Media LLC, 2020.

Abstract

Background Dysautonomic symptoms (DS) are frequent but often underrecognized in multiple sclerosis (MS) patients, despite the relevant impact on quality of life and physical performance. Objectives To assess frequency and characteristics of DS in our MS population compared with healthy controls (HC). To investigate the relationship between DS and disease characteristics (MS subtype, disease duration, Expanded Disability Status Scale (EDSS), clinical and/or radiological activity, disability progression). Patients and methods Cross-sectional study includes 324 MS patients (mean age 44.9 ± 10.7 years; 66% female) and 190 HC (mean age 40.60 ± 12.83 years; 63% female). DS were assessed using the Italian validated version of the Composite Autonomic Symptom Score-31 (COMPASS-31). Possible confounding factors were considered. Results More than 94% of enrolled MS patients reported alterations in ≥ 2 domains of the COMPASS-31 scale (score > 0) and significantly higher COMPASS-31 total and single domain median scores compared with HC, independently from possible confounding factors (orthostatic intolerance: p = 0.001; vasomotor: p = 0.017; secretomotor: p = 0.040; gastrointestinal: p = 0.047; bladder: p p p p p = 0.01; Rho = 0.25, p = 0.030; Rho = 0.28, p p p p = 0.025), gastrointestinal (p = 0.07), and bladder (p Conclusions Our findings confirm that MS-related DS are frequent and tend to increase paralleling disease duration and clinical worsening, reaching the highest clinical impact in progressive subtypes.

Details

ISSN :
15903478 and 15901874
Volume :
42
Database :
OpenAIRE
Journal :
Neurological Sciences
Accession number :
edsair.doi.dedup.....855b319561b89ad98d7aded7d2aa76c6
Full Text :
https://doi.org/10.1007/s10072-020-04620-1